Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nitsan Haham

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal of Neuroimmunology|August 14, 2021
COVID-19 in Cladribine-treated patient with multiple sclerosisNitsan Haham, Adi Vaknin-Dembinsky
Journal of Neuroimmunology|May 4, 2024
A protective effect of lower MHC-II expression in MOGADAriel Rechtman, Omri Zveik, Nitsan Haham, et al.
Journal of Neuroimmunology|February 1, 2024
Altered immune co-inhibitory receptor expression and correlation of LAG-3 expression to disease severity in NMOSDNitsan Haham, Omri Zveik, Ariel Rechtman, et al.
Journal of the Neurological Sciences|January 19, 2024
Thyroid hormone dysfunction in MOGAD and other demyelinating diseasesAriel Rechtman, Omri Zveik, Nitsan Haham, et al.
Journal of Neuroimmunology|December 3, 2019
MIF -173G/C polymorphism is associated with NMO disease severityLivnat Brill, Adi Vaknin-Dembinsky, Omri Zveik, et al.
Frontiers in Medicine|September 22, 2025
Late vs. early intrauterine blood transfusion in fetal anemia: impact on maternal and neonatal outcomesAdva Cahen Peretz, Lilah Tsaitlin-Mor, Gideon Leibner, et al.
Journal of Inherited Metabolic Disease|July 23, 2024
The natural history of dihydrolipoamide dehydrogenase deficiency in IsraelBen Pode-Shakked, Yuval E Landau, Nava Shaul Lotan, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of Neuroimmunology|August 14, 2021
COVID-19 in Cladribine-treated patient with multiple sclerosisNitsan Haham, Adi Vaknin-Dembinsky
Journal of Neuroimmunology|May 4, 2024
A protective effect of lower MHC-II expression in MOGADAriel Rechtman, Omri Zveik, Nitsan Haham, et al.
Journal of Neuroimmunology|February 1, 2024
Altered immune co-inhibitory receptor expression and correlation of LAG-3 expression to disease severity in NMOSDNitsan Haham, Omri Zveik, Ariel Rechtman, et al.
Journal of the Neurological Sciences|January 19, 2024
Thyroid hormone dysfunction in MOGAD and other demyelinating diseasesAriel Rechtman, Omri Zveik, Nitsan Haham, et al.
Journal of Neuroimmunology|December 3, 2019
MIF -173G/C polymorphism is associated with NMO disease severityLivnat Brill, Adi Vaknin-Dembinsky, Omri Zveik, et al.
Frontiers in Medicine|September 22, 2025
Late vs. early intrauterine blood transfusion in fetal anemia: impact on maternal and neonatal outcomesAdva Cahen Peretz, Lilah Tsaitlin-Mor, Gideon Leibner, et al.
Journal of Inherited Metabolic Disease|July 23, 2024
The natural history of dihydrolipoamide dehydrogenase deficiency in IsraelBen Pode-Shakked, Yuval E Landau, Nava Shaul Lotan, et al.
Pageof 1